Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03255967 · ClinicalTrials.gov registry record · NA
Dementia Symptom Management at Home Program
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
NCT03255967 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 217 participants.
The verdict
NCT03255967, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
Study Summary
Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare, most home healthcare clinicians and agencies are ill prepared to care for this population and therefore have difficulty assisting patients and caregivers in maintaining quality of life leading to adverse patient outcomes, increased caregiver stress and burnout, and healthcare utilization. This study will therefore utilize a cluster randomized controlled design at 3 study sites to examine the ability of a multi-component evidence-based practice primary palliative care quality improvement program for home healthcare registered nurses, occupational therapists and physical therapists to improve the quality of life and reduce healthcare utilization for persons with dementia and their informal caregiver.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL DSM-H
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2018-08-16 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03255967
The ClinicalTrials.gov registry entry for NCT03255967 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03255967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03255967 about?
NCT03255967 is a clinical study titled "Dementia Symptom Management at Home Program". Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare, most home healthcare clinicians and agencies are ill prepared to care...
What is the current status of trial NCT03255967?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2018-08-16. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03255967?
The interventions under investigation include: Standard of Care (BEHAVIORAL), DSM-H (BEHAVIORAL).
Who is sponsoring clinical trial NCT03255967?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.